We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

By LabMedica International staff writers
Posted on 15 Jun 2026

Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. More...

Symptoms can begin in the newborn period and progress to recurrent respiratory infections that damage the lungs over time. Inflammation can persist even when patients are not acutely ill, complicating assessment and management. To help address this challenge, researchers have identified hidden systemic inflammatory patterns and a noninvasive way to detect them between exacerbations.

Investigators at UTHealth Houston’s McGovern Medical School identified distinct, previously unrecognized forms of systemic inflammation in children with primary ciliary dyskinesia. The findings were published in the Annals of the American Thoracic Society. The study, titled “Multi-Omics Analysis Defines Endotypes and Systemic Inflammation in Primary Ciliary Dyskinesia: A Comparison with Healthy Controls,” links clinically stable disease to measurable inflammatory signatures outside of acute illness.

The team found that a simple oral swab detected the same inflammatory signals identified in blood. This approach offers a needle-free method to identify and monitor ongoing inflammation during routine care. Detecting these systemic signals when patients feel well may help clinicians understand why lung disease worsens over time despite the absence of overt symptoms.

Researchers evaluated patients from the United States, Puerto Rico, and Mexico, showing that home-based saliva collection is feasible across diverse populations. The ability to collect samples at home could improve patient comfort and increase monitoring frequency without additional clinic visits. This framework supports remote assessment strategies suited to pediatric populations and families managing chronic respiratory conditions.

According to the team, oral swab-based inflammatory profiling may guide the use of existing anti-inflammatory therapies and support more precise tracking of treatment response. The researchers anticipate that individualized inflammatory profiles could help select the most effective options for each child. They also note that persistent inflammation underlies many chronic lung diseases, suggesting the approach could inform care beyond primary ciliary dyskinesia.

Related Links
UTHealth Houston


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.